InsiderTrades

Form 4 for WVE Wave Life Sciences, Inc.

Accepted 2022-06-21 00:00:00 ET · period of report 2022-06-16 · accession 0001104659-22-072990 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2022-06-21 2022-06-16 WVE RA Capital Healthcare Fund LP Dir, 10% P - Purchase $2.15 +9.48M 17.20M +123% +$20.38M
DI 2022-06-21 2022-06-16 WVE RA Capital Healthcare Fund LP Dir, 10% P - Purchase $2.15 +7.09M 7.09M New +$15.25M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Ordinary Shares 2022-06-16 P A 9,480,052 $2.15 17,202,009 I See Footnotes — — (F1) These Securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund") (F2) RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
2 Derivative Pre-Funded Warrants (Right to Buy) 2022-06-16 P A 7,093,656 $2.15 7,093,656 I See Footnotes $0.00 · — to 2027-06-16 7,093,656 Ordinary Shares (F2) RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. (F1) These Securities are held directly by RA Capital Healthcare Fund, L.P. (the "Fund") (F3) The Pre-Funded Warrants are exercisable immediately and will be exercisable until exercised in full. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's ordinary shares would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's ordinary shares outstanding immediately after giving effect to such exercise.